腹腔镜下根治性切除术治疗Ⅳ型肝门部胆管癌的效果分析

徐建; 张薇; 邬长康; 武国; 李敬东

doi:10.3969/j.issn.1001-5256.2019.03.022

腹腔镜下根治性切除术治疗Ⅳ型肝门部胆管癌的效果分析

DOI: 10.3969/j.issn.1001-5256.2019.03.022

1. 川北医学院附属医院肝胆外科
2. 川北医学院肝胆胰肠研究所

基金项目:

四川省教育厅创新团队项目(10TD0025)；

详细信息

中图分类号: R735.8
计量
- 文章访问数: 1459
- HTML全文浏览量: 35
- PDF下载量: 315
- 被引次数: 0
出版历程
- 出版日期: 2019-03-20

Clinical effect of laparoscopic radical resection in treatment of type Ⅳ hilar cholangiocarcinoma

Department of Hepatobiliary Surgery, Affiliated Hospital of Chuanbei Medical College

Research funding:

摘要

摘要:
目的探讨Ⅳ型肝门部胆管癌（pCCA）行腹腔镜下根治性切除术的可行性及安全性。方法回顾性分析川北医学院附属医院2015年7月-2018年9月收治的4例行腹腔镜根治性切除术并经术后病理证实为肝门部胆管癌（Ⅳ型）患者的临床资料,其中男2例,女2例,年龄53～65岁,平均年龄59. 4岁。所有患者术前均存在不同程度黄疸,术前给予保肝、退黄、营养支持等对症治疗,2例患者术前行经皮肝穿刺胆道引流术减黄。结果 4例患者均顺利完成腹腔镜下根治性切除术,其中3例行左半肝切除+全尾叶切除术+淋巴结清扫+胆肠吻合术; 1例患者行扩大右半肝切除+全尾叶切除术+淋巴结清扫+胆肠吻合术。手术时间5.5～8. 5 h,术中出血量200～750 ml,其中1例患者术中输血400 ml。术后1例患者出现胆漏,经保守持续引流后好转出院,1例患者术后发生大量腹水,给予护肝、利尿等对症治疗后出院,余患者未发生围手术期并发症。术后随访3～24个月,1例患者术后11个月发生肝内转移,行介入治疗后目前带瘤生存4个月。结论在术前充分评估、严格掌握手术适应证、熟练的腹腔镜技术以及规范化操作的基础上,Ⅳ型pCCA行腹腔镜下根治性切除术是...
- 胆管肿瘤 /
- 腹腔镜 /
- 肝切除术 /
- 治疗结果
Abstract:
Objective To investigate the feasibility and safety of laparoscopic radical resection in the treatment of type IV hilar cholangio-carcinoma. Methods A retrospective analysis was performed for the clinical data of 4 patients who were admitted to the Affiliated Hospitalof Chuanbei Medical College from July 2015 to September 2018, underwent laparoscopic radical resection, and were diagnosed with type IVhilar cholangiocarcinoma based on postoperative pathology. There were 2 female and 2 male patients aged 53-65 years, with a mean age of59. 4 years. All patients had varying degrees of jaundice before surgery and were given symptomatic treatment including liver-protectingtreatment, jaundice clearance, and nutritional support. Two patients underwent percutaneous transhepatic biliary drainage before surgery toalleviate jaundice. Results All 4 patients underwent a successful laparoscopic surgery, among whom 3 underwent left hemihepatectomy +total caudate lobe resection + lymph node dissection + choledochoenterostomy, and 1 underwent extensive right hemihepatectomy + total cau-date lobe resection + lymph node dissection + choledochoenterostomy. Time of operation was 5. 5-8. 5 hours, and intraoperative blood lossranged from 200 to 750 ml, with 400 ml intraoperative blood transfusion in 1 patient. After surgery, 1 patient had bile leakage and was im-proved and discharged after conservative continuous drainage; 1 patient had massive ascites and was discharged after liver-protecting anddiuretic treatment; no perioperative complication was observed in the other 2 patients. The patients were followed up for 3-24 months aftersurgery; 1 patient developed intrahepatic metastasis at 11 months after surgery and had survived with tumor for 4 months after interventionaltherapy. Conclusion With adequate preoperative assessment, strict control of surgical indications, skilled laparoscopic technique, andstandardized operation, laparoscopic radical resection is feasible and safe in the treatment of type IV hilar cholangiocarcinoma. R0 resectionis an important prognostic factor.
- bile duct neoplasms /
- laparoscopes /
- hepatectomy /
- treatment outcome

HTML全文

参考文献(22)

[1] Anti-cancer Association of China. Guideline for the diagnosisand therapy of hilar cholangiocarcinoma (2015) [J]. Chin JHepatobiliary Surg, 2015, 21 (8) :505-511. (in Chinese) 中国抗癌协会.肝门部胆管癌规范化诊治专家共识 (2015) [J].中华肝胆外科杂志, 2015, 21 (8) :505-511.

[2] PALANIVELU C, JMFI K, SENTHILNATHAN P, et al. Laparo-seopie pancreaticoduodenectomy:Technique and outcomes[J]. J Am Coil Surg, 2007, 205 (2) :222-230.

[3] HUANG ZQ. Management of hilar cholangiocarcinoma:Re-view of a 25-year experience[J]. Chin J Dig Surg, 2010, 9 (3) :161-164. (in Chinese) 黄志强.肝门部胆管癌外科治疗25年的历程[J].中华消化外科杂志, 2010, 9 (3) :161-164.

[4] CHEN ZY, BIE P. Clinical application of combined vascular re-section and reconstruction in surgical treatment of hilar cholan-giocarcinoma[J]. J Clin Hepatol, 2016, 32 (7) :1277-1279. (in Chinese) 陈志宇, 别平.联合血管切除与重建在肝门部胆管癌外科治疗中的应用[J].临床肝胆病杂志, 2016, 32 (7) :1277-1279.

[5] YIN XM, LIU YL, CHENG W, et al. Clinical application valueof total laparoscopic radical resection ofⅣ-type hilar choan-giocarcinoma:Video attached[J/CD]. Chin J Hepat Surg:E-lectronic Edition, 2018, 7 (2) :110-114. (in Chinese) 尹新民, 刘雅玲, 成伟, 等.全腹腔镜Ⅳ型肝门部胆管癌根治术的临床应用价值 (附视频) [J/CD].中华肝脏外科手术学电子杂志, 2018, 7 (2) :110-114.

[6] RASSAM F, ROOS E, van LIENDEN KP, et al. Modern work-up and extended resection in perihilar cholangiocarcinoma:The AMC experience[J]. Langenbecks Arch Surg, 2018, 403 (3) :289-307.

[7] SHARPE SM, TALAMONTI MS, WANG CE, et al. Early nation-al experience with laparoseopic panereaticoduodeneetomy forduetal adenocarcinoma:A comparison of laparoseopie pan-creaticoduodenectomy and open pancreaticoduodeneetomyfrom the national cancer data base[J]. J Am Cou Surg, 2015, 221 (1) :175-184.

[8] MOLINA V, SAMPSON J, FERRER J, et al. Klatskin tumor:Diagnosis, preoperative evaluation and surgical considerations[J]. Cir Esp, 2015, 93 (9) :552-560.

[9] YI B, ZHANG BH, ZHANG YJ, et al. Analysis of the relationbetween surgery and prognosis of hilar cholangiocarcinoma[J]. Chin J Surg, 2005, 43 (13) :842-845. (in Chinese) 易滨, 张柏和, 张永杰, 等.手术方式与肝门部胆管癌预后的关系分析[J].中华外科杂志, 2005, 43 (13) :842-845.

[10] HAN HS, CHO JY, YOON YS, et al. Total laparoscopic livingdonor right hepatectomy[J]. Surg Endosc, 2015, 29 (1) :184.

[11] FANG CH, LI QL, CAI W. Translational application of three-dimensional visualization technology in the diagnosis and treat-ment of hilar cholangiocarcinoma[J]. Chin J Dig Surg, 2018, 17 (4) :343-346. (in Chinese) 方驰华, 李乔林, 蔡伟.从数字虚拟人技术到数字化微创外科:三维可视化技术在肝门部胆管癌诊断与治疗中的转化应用[J].中华消化外科杂志, 2018, 17 (4) :343-346.

[12] CHEN XP, XIANG S. Therapy of hilar cholangiocarcinoma inthe precise medicine period[J]. Chin J Dig Surg, 2018, 17 (1) :3-8. (in Chinese) 陈孝平, 项帅.精准医学时代肝门部胆管癌的治疗[J].中华消化外科杂志, 2018, 17 (1) :3-8.

[13] BO XB, WANG YQ, LIU HB. Preoperative evaluation of peri-hilar cholangiocarcinoma[J/CD]. Chin J Hepat Surg:Elec-tronic Edition, 2018, 7 (4) :258-262. (in Chinese) 薄晓波, 王越琦, 刘厚宝.肝门部胆管癌术前评估[J/CD].中华肝脏外科手术学电子杂志, 2018, 7 (4) :258-262.

[14] MAYO SC, AUSTIN DF, SHEPPARD BC, et al. Evolving pre-operative evaluation of patients with pancreatic cancer:Doeslaparoscopy have a role in the current era[J]. J Am CollSurg, 2009, 208 (1) :87-95.

[15] Biliary Tract Group, Chinese Society of Surgery, ChineseMedical Association; PLA Professional Committee on Hepato-biliary Surgery. Guidelines for the diagnosis and treatment ofhilar Cholangiocarcinoma (2013) [J]. Chin J Surg, 2013, 51 (10) :865-871. (in Chinese) 中华医学会外科学分会胆道外科学组, 解放军全军肝胆外科专业委员会.肝门部胆管癌诊断和治疗指南 (2013版) [J].中华外科杂志, 2013, 51 (10) :865-871.

[16] ZHANG CW, LIU J, HONG DF, et al. Pure laparoscopic radi-cal resection for type IIIa hilar cholangiocarcinoma[J]. SurgEndosc, 2018, 32 (3) :1581-1582.

[17] CHO A, YAMAMOTO H, KAINUMA O, et al. Laparoscopy inthe management of hilar cholangiocarcinoma[J]. World JGastroenterology, 2014, 20 (41) :15153-15157.

[18] HAN IW, JANG JY, KANG MJ, et al. Role of resection for Bis-muth type IV hilar cholangiocarcinoma and analysis of determi-ning factors for curative resection[J]. Ann Surg Treat Res, 2014, 87 (2) :87-93.

[19] PUNTAMBEKAR S, SHARMA V, KUMAR S, et al. Laparo-scopic management of hilar cholangiocarcinoma:A case re-port[J]. Indian J Surg, 2016, 78 (1) :57-59.

[20] LEE W, HAN HS, YOON YS, et al. Laparoscopic resection ofhilar cholangiocarcinoma[J]. Ann Surg Treat Res, 2015, 89 (4) :228-232.

[21] YU H, WU SD, CHEN DX, et al. Laparoscopic resection ofBismuth type I and II hilar cholangiocarcinoma:An audit of 14cases from two institutions[J]. Dig Surg, 2011, 28 (1) :44-49.

[22] KENDRICK ML, CUSATI D. Total laparoscopic pancreaticodu-odenectomy:Feasibility and outcome in an early experience[J]. Arch Surg, 2010, 145 (1) :19-23.

施引文献

资源附件(0)

访问统计